Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression
NCT00232167 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 380
Last updated 2007-10-02
Summary
The goal of this study is to determine whether indiplon, when administered with sertraline, improves insomnia symptoms and depressive symptoms in subjects with both insomnia and depression.
Conditions
Interventions
- DRUG
-
Indiplon
- DRUG
-
Sertraline
Sponsors & Collaborators
-
Neurocrine Biosciences
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-11-30
- Completion
- 2006-04-30
More Related Trials
-
Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome
NCT00149825 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD)
NCT00275197 ·Status: COMPLETED ·Phase: PHASE2
-
Intensive Accelerated iTBS for the Treatment-Resistant Depression
NCT06166082 ·Status: COMPLETED ·Phase: NA
-
The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression
NCT06827431 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Ketamine and Nitroprusside for Depression
NCT03102736 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD)
NCT00321152 ·Status: COMPLETED ·Phase: PHASE4
-
STILDEP: Zolpidem in Depressive and Dysthimic Patients
NCT00292734 ·Status: COMPLETED ·Phase: PHASE4
-
Study of 6(S)-5-MTHF Among Selective Serotonin Reuptake Inhibitor-Resistant Outpatients With Major Depressive Disorder
NCT00955955 ·Status: COMPLETED ·Phase: PHASE4
-
Simvastatin as an Augmentation Treatment for Treatment Resistant Depression: Randomized Controlled Trial.
NCT03435744 ·Status: COMPLETED ·Phase: PHASE3
-
Placebo Effects in the Treatment of Depression: Cognitive and Neural Mechanisms
NCT01919216 ·Status: COMPLETED ·Phase: PHASE4
-
TC-5214 as add-on the Treatment of Major Depressive Disorder
NCT00692445 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive and Drug Therapy for Drug-Resistant Depression
NCT00000376 ·Status: COMPLETED ·Phase: NA
-
TRIAD - Treatment of Insomnia and Depression
NCT00767624 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatments for Psychogenic Nonepileptic Seizures (NES)
NCT00159965 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Sertraline to Prevent PTSD
NCT00182078 ·Status: COMPLETED ·Phase: PHASE4
-
Open-Label Placebo for the Treatment of Depression
NCT02666989 ·Status: UNKNOWN ·Phase: NA
-
Deprexil in Subjects With Signs and Symptoms of Depression
NCT01043367 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Effect of Antidepressant Drugs on Neurotrophic Factors in Patients With Depression
NCT03126188 ·Status: COMPLETED
-
Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder
NCT00143091 ·Status: TERMINATED ·Phase: PHASE2
-
Ziprasidone and Sertraline in PTSD
NCT00248261 ·Status: TERMINATED
-
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
NCT06592833 ·Status: RECRUITING ·Phase: PHASE2
-
A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression.
NCT00636246 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis
NCT01001559 ·Status: COMPLETED
-
Interpersonal Psychotherapy for Treatment Resistant Depression
NCT01896349 ·Status: UNKNOWN ·Phase: NA
-
Serotonin Function During Depression
NCT00033787 ·Status: COMPLETED